Vaccine durability questions, gene therapy gains and FDA policy concerns.
November 26, 2025

1. Novo Nordisk GLP-1 fails to slow Alzheimer's in trials Full story

2. Measles vaccine immunity fades after 10 years: Study Full story

3. 2026 strategy check: Are your assumptions about care delivery still holding up? Get answers here.

 

4. Eli Lilly 1st pharma company to reach $1 trillion market cap Full story

5. FDA approves all-ages gene therapy for spinal condition Full story

6. Price isn't everything anymore — See how systems are redefining purchasing value, here.

 

7. Lawmakers raise concerns over FDA drug voucher program Full story

8. 5 new drug shortages Full story

Becker's Learning Opportunities

9. Top AI leaders reveal how healthcare can harness new tools to streamline workflows and enhance care here.

10. Infusion volume is up. Hartford HealthCare's staffing fix is working — see it here.

11. HIPAA risk from unsecured messages? Build governed AI communications workflows here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication